453566-15-9 Usage
Uses
Used in Pharmaceutical Research:
3-Bromo-5-cyanobenzoic acid methyl ester is used as a building block in pharmaceutical research for the preparation of various pharmaceutical compounds. Its unique chemical structure allows it to be a key component in the synthesis of new drugs with potential therapeutic applications.
Used in Agrochemicals:
3-Bromo-5-cyanobenzoic acid methyl ester is also used in the development of agrochemicals, where it serves as a starting material for the synthesis of various agrochemical products. Its versatility in organic synthesis makes it a valuable compound in the creation of new and effective agrochemicals.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Bromo-5-cyanobenzoic acid methyl ester is used as a versatile intermediate for the preparation of a wide range of organic compounds. Its reactivity and functional groups make it a suitable candidate for various chemical reactions, leading to the formation of diverse organic molecules with different applications.
Check Digit Verification of cas no
The CAS Registry Mumber 453566-15-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,5,3,5,6 and 6 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 453566-15:
(8*4)+(7*5)+(6*3)+(5*5)+(4*6)+(3*6)+(2*1)+(1*5)=159
159 % 10 = 9
So 453566-15-9 is a valid CAS Registry Number.
453566-15-9Relevant articles and documents
MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
-
, (2020/10/18)
Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.
ANILINE DERIVATIVES,THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
-
, (2013/03/28)
The present invention relates to aniline derivatives, to their preparation and to their therapeutic application.
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
-
, (2008/06/13)
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.